(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.02%) 15 928 points
(-0.81%) $83.17
(0.99%) $1.942
(-0.39%) $2 338.10
(0.02%) $27.54
(0.72%) $928.70
(-0.16%) $0.933
(-0.12%) $11.01
(-0.22%) $0.799
(0.25%) $92.11
Live Chart Being Loaded With Signals
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition...
Stats | |
---|---|
本日の出来高 | 902.00 |
平均出来高 | 1 055.00 |
時価総額 | 6.61M |
EPS | $0 ( 2024-04-01 ) |
次の収益日 | ( $0 ) 2024-05-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.670 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Galligan Joseph J | Buy | 5 566 | Common Stock, par value $0.001 |
2024-01-02 | Galligan Joseph J | Buy | 6 173 | Common Stock, par value $0.001 |
2024-03-28 | Granier Brady James | Buy | 16 698 | Stock Option |
2024-03-28 | Murthy Harsha | Buy | 5 566 | Common Stock, par value $0.001 |
2024-01-02 | Murthy Harsha | Buy | 6 173 | Common Stock, par value $0.001 |
INSIDER POWER |
---|
100.00 |
Last 98 transactions |
Buy: 888 470 | Sell: 0 |
BioCorRx Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
BioCorRx Inc. 財務諸表
Annual | 2023 |
収益: | $89 160.00 |
総利益: | $-146 762 (-164.61 %) |
EPS: | $-0.450 |
FY | 2023 |
収益: | $89 160.00 |
総利益: | $-146 762 (-164.61 %) |
EPS: | $-0.450 |
FY | 2022 |
収益: | $213 841 |
総利益: | $198 562 (92.85 %) |
EPS: | $-0.610 |
FY | 2021 |
収益: | $48 272.00 |
総利益: | $42 391.00 (87.82 %) |
EPS: | $-0.810 |
Financial Reports:
No articles found.
BioCorRx Inc.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。